{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210610",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 3",
          "submission_class_code_description": "Type 3 - New Dosage Form",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "67779",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215110Orig1s000; 209394Orig1s013ltr.pdf",
              "date": "20210614",
              "type": "Letter"
            },
            {
              "id": "67885",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215110s000,209394s013lbl.pdf",
              "date": "20210624",
              "type": "Label"
            },
            {
              "id": "69283",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215110Orig1s000TOC.html",
              "date": "20211109",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20250610",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "82535",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209394s019,215110s005lbl.pdf",
              "date": "20250611",
              "type": "Label"
            },
            {
              "id": "82545",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/209394Orig1s019;215110Orig1s005ltr.pdf",
              "date": "20250612",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20231025",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "75949",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/209394Orig1s016;215110Orig1s003ltr.pdf",
              "date": "20231026",
              "type": "Letter"
            },
            {
              "id": "75974",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209394s016,215110s003lbl.pdf",
              "date": "20231027",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210928",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "68803",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/215110Orig1s001;209394Orig1s014ltr.pdf",
              "date": "20210929",
              "type": "Letter"
            },
            {
              "id": "68863",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209394s014,215110s001lbl.pdf",
              "date": "20211001",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA215110",
      "sponsor_name": "ABBVIE",
      "openfda": {
        "application_number": [
          "NDA215110"
        ],
        "brand_name": [
          "MAVYRET"
        ],
        "generic_name": [
          "GLECAPREVIR AND PIBRENTASVIR"
        ],
        "manufacturer_name": [
          "AbbVie Inc."
        ],
        "product_ndc": [
          "0074-2600",
          "0074-2625"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "GLECAPREVIR",
          "PIBRENTASVIR"
        ],
        "rxcui": [
          "1940703",
          "1940709",
          "2557906",
          "2557910"
        ],
        "spl_id": [
          "2c392930-500d-4e9b-93ac-317c4d48251c"
        ],
        "spl_set_id": [
          "7bf99777-0401-9095-8645-16c6e907fcc0"
        ],
        "package_ndc": [
          "0074-2625-28",
          "0074-2625-56",
          "0074-2625-01",
          "0074-2625-80",
          "0074-2625-84",
          "0074-2625-04",
          "0074-2600-28"
        ],
        "nui": [
          "N0000191256",
          "N0000185503",
          "N0000190113",
          "N0000190107",
          "N0000190108",
          "N0000190114",
          "N0000182138",
          "N0000191272",
          "N0000182639",
          "N0000182638"
        ],
        "pharm_class_epc": [
          "Hepatitis C Virus NS5A Inhibitor [EPC]",
          "Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "Cytochrome P450 1A2 Inhibitors [MoA]",
          "UGT1A1 Inhibitors [MoA]",
          "HCV NS3/4A Protease Inhibitors [MoA]"
        ],
        "unii": [
          "2WU922TK3L",
          "K6BUU8J72P"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "MAVYRET",
          "active_ingredients": [
            {
              "name": "GLECAPREVIR",
              "strength": "50MG/PACKET"
            },
            {
              "name": "PIBRENTASVIR",
              "strength": "20MG/PACKET"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "PELLETS",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}